See more : Brookfield Property Partners L.P. (BPYPO) Income Statement Analysis – Financial Results
Complete financial analysis of Canopy Growth Corporation (CGC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Canopy Growth Corporation, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Topgolf Callaway Brands Corp. (MODG) Income Statement Analysis – Financial Results
- Guangdong Shunna Electric Co., Ltd (000533.SZ) Income Statement Analysis – Financial Results
- Henry Schein, Inc. (HS2.DE) Income Statement Analysis – Financial Results
- New Talisman Gold Mines Limited (NTL.AX) Income Statement Analysis – Financial Results
- Guangdong Golden Dragon Development Inc. (000712.SZ) Income Statement Analysis – Financial Results
Canopy Growth Corporation (CGC)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.canopygrowth.com
About Canopy Growth Corporation
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 297.15M | 402.90M | 520.33M | 546.65M | 398.77M | 226.34M | 77.95M | 39.90M | 12.70M | 1.15M | 0.00 | 4.14K | 0.00 | 4.49K | 549.00 |
Cost of Revenue | 216.26M | 507.04M | 713.38M | 479.69M | 430.46M | 137.41M | 3.76M | 2.26M | -6.29M | 731.31K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 80.88M | -104.14M | -193.05M | 66.96M | -31.68M | 88.93M | 74.19M | 37.63M | 18.99M | 414.35K | 0.00 | 4.14K | 0.00 | 4.49K | 549.00 |
Gross Profit Ratio | 27.22% | -25.85% | -37.10% | 12.25% | -7.95% | 39.29% | 95.18% | 94.33% | 149.51% | 36.17% | 0.00% | 100.00% | 0.00% | 100.00% | 100.00% |
Research & Development | 4.61M | 21.72M | 32.34M | 57.58M | 61.81M | 15.24M | 1.45M | 810.00K | 721.00K | 159.65K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 99.83M | 487.41M | 520.28M | 666.54M | 624.91M | 451.44M | 92.93M | 25.59M | 11.67M | 6.00M | 739.94K | 68.75K | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 76.15M | 243.45M | 239.28M | 194.40M | 242.83M | 154.39M | 38.20M | 12.96M | 5.65M | 1.99M | 191.72K | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 175.98M | 487.41M | 520.28M | 666.54M | 867.74M | 605.83M | 131.13M | 38.55M | 17.33M | 7.99M | 931.66K | 68.75K | 26.16K | 28.56K | 27.47K |
Other Expenses | 129.01M | -21.72M | -32.34M | -57.58M | 63.62M | 21.51M | 20.49M | -585.00K | 2.26M | -966.30K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 309.60M | 487.41M | 520.28M | 666.54M | 993.17M | 642.58M | 153.07M | 45.43M | 20.30M | 8.15M | 931.66K | 68.75K | 26.16K | 28.56K | 27.47K |
Cost & Expenses | 525.86M | 994.46M | 1.23B | 1.15B | 1.42B | 779.99M | 156.82M | 47.69M | 14.02M | 8.88M | 931.66K | 68.75K | 26.16K | 28.56K | 27.47K |
Interest Income | 16.24M | 24.28M | 6.60M | 21.37M | 66.33M | 49.31M | 1.35M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.76K | 4.49K | 549.00 |
Interest Expense | 105.35M | 126.16M | 103.94M | 8.46M | 6.72M | 18.42M | 784.00K | 66.00K | 140.00K | 65.82K | 1.27K | 0.00 | 4.76K | 4.49K | 0.00 |
Depreciation & Amortization | 53.18M | 80.03M | 114.42M | 127.12M | 125.01M | 46.92M | 20.49M | 6.06M | 2.26M | 362.90K | 4.19K | 0.00 | -4.76K | -4.49K | 0.00 |
EBITDA | -312.83M | -2.88B | -121.15M | -1.50B | -1.31B | -631.83M | -29.80M | -692.00K | 938.00K | -6.96M | -925.99K | -64.61K | -26.16K | -24.07K | -26.92K |
EBITDA Ratio | -105.28% | 434.27% | -44.12% | 31.36% | -340.35% | -213.54% | -118.58% | 17.12% | 20.27% | -618.02% | 0.00% | -1,559.07% | 0.00% | -536.27% | -4,903.10% |
Operating Income | -228.71M | 1.67B | -1.08B | 44.30M | -1.67B | -553.65M | -78.88M | -15.22M | -2.75M | -7.74M | -931.66K | -64.61K | -21.39K | -19.58K | -26.92K |
Operating Income Ratio | -76.97% | 413.30% | -208.08% | 8.10% | -418.53% | -244.61% | -101.19% | -38.14% | -21.65% | -675.34% | 0.00% | -1,559.07% | 0.00% | -436.27% | -4,903.10% |
Total Other Income/Expenses | -242.64M | -455.64M | 750.94M | -440.51M | 159.91M | -59.71M | 68.53M | 3.81M | -621.00K | -912.37K | -1.27K | 0.00 | 0.00 | 0.00 | 26.92K |
Income Before Tax | -471.36M | -3.31B | -329.43M | -1.68B | -1.51B | -657.78M | -52.54M | -17.06M | -3.37M | -8.93M | -932.93K | -64.61K | -21.39K | 0.00 | 0.00 |
Income Before Tax Ratio | -158.63% | -822.61% | -63.31% | -308.05% | -378.43% | -290.61% | -67.41% | -42.76% | -26.54% | -779.58% | 0.00% | -1,559.07% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 12.33M | -4.77M | -8.95M | -13.14M | -121.61M | 12.32M | 1.59M | -401.00K | 126.00K | 1.42M | 2.75K | 0.00 | -4.76K | -4.49K | 26.92K |
Net Income | -657.27M | -3.31B | -320.49M | -1.67B | -1.39B | -670.09M | -54.13M | -16.61M | -3.50M | -8.93M | -932.93K | -64.61K | -21.39K | -24.07K | -26.92K |
Net Income Ratio | -221.19% | -821.42% | -61.59% | -305.65% | -347.93% | -296.06% | -69.45% | -41.63% | -27.53% | -779.58% | 0.00% | -1,559.07% | 0.00% | -536.27% | -4,903.10% |
EPS | -6.47 | -71.37 | -8.19 | -44.96 | -39.86 | -1.99 | -0.31 | -0.14 | -0.05 | -0.30 | -15.77 | -0.06 | -0.02 | -0.02 | -0.08 |
EPS Diluted | -8.79 | -71.37 | -8.19 | -44.96 | -39.86 | -1.99 | -0.31 | -0.14 | -0.05 | -0.30 | -15.77 | -0.06 | -0.02 | -0.02 | -0.08 |
Weighted Avg Shares Out | 101.63M | 46.37M | 39.13M | 37.17M | 34.80M | 337.51M | 177.30M | 118.99M | 77.02M | 29.95M | 59.16K | 1.00M | 1.00M | 1.00M | 320.24K |
Weighted Avg Shares Out (Dil) | 74.79M | 46.37M | 39.13M | 37.17M | 34.80M | 337.51M | 177.30M | 118.99M | 77.02M | 29.95M | 59.16K | 1.00M | 1.00M | 1.00M | 320.24K |
Canopy Growth's Seasonal Essentials for Gifting, Gathering, and Unwinding
Canopy Growth Corporation (CGC) is Attracting Investor Attention: Here is What You Should Know
3 Marijuana Stocks For Your Holiday Trading
Struggling pot company Canopy Growth taps turnaround pro from outside the industry as CEO
Canopy Growth Announces Mr. Luc Mongeau As The Company's Next CEO
Acreage Provides Update on Corporate Transactions
The U.S. Cannabis Strategy No One's Talking About: Inside Canopy's $300M Plan
Canopy Growth Launches Claybourne Infused Pre-Rolls in Canada
Canadian Gold Corp. Announces Non-Brokered Financing to Advance Phase 4 Exploration at Tartan
The Top Canadian Cannabis Stocks for November 2024 Growth
Source: https://incomestatements.info
Category: Stock Reports